Immunology and Serology

Extractable Nuclear Antigen (ENA) Panel

← Back to Test Menu

Extractable Nuclear Antigen (ENA) Panel

What is an ENA Panel?

The Extractable Nuclear Antigen (ENA) Panel is a blood test that detects specific autoantibodies directed against proteins found in the cell nucleus.

These antibodies are associated with several systemic autoimmune and connective tissue diseases, including systemic lupus erythematosus (SLE), Sjögren syndrome, systemic sclerosis (scleroderma), mixed connective tissue disease, and inflammatory muscle diseases.

The ENA panel is often performed after an ANA (antinuclear antibody) test is positive, helping identify which specific autoantibodies are present.

What is it used for?

The ENA Panel may help:

Support the diagnosis of systemic autoimmune diseases

Identify specific autoantibody patterns after a positive ANA

Differentiate between certain connective tissue diseases

Evaluate patients with symptoms suggestive of systemic autoimmune disease

Support disease classification and clinical assessment

What antibodies are included in an ENA Panel?

The exact composition varies between laboratories and testing platforms. A typical ENA Panel may include:

Autoantibody Common clinical associations

Anti-Ro/SSA Sjögren syndrome, SLE, subacute cutaneous lupus; important in pregnancy because of fetal/neonatal risks

Anti-La/SSB Sjögren syndrome and SLE

Anti-Sm (Smith) Highly specific for SLE

Anti-RNP Mixed connective tissue disease (MCTD), SLE and other connective tissue diseases

Anti-Scl-70 (Topoisomerase I) Systemic sclerosis, particularly diffuse cutaneous disease

Anti-Jo-1 Polymyositis/dermatomyositis and antisynthetase syndrome

Some expanded ENA panels may also include anti-centromere, anti-RNA polymerase III, anti-PM/Scl, anti-Chromatin, anti-Ribosomal P, or other antibodies.

Therefore, the laboratory's specific test menu should be checked when interpreting an ENA Panel.

Why might I need an ENA Panel?

Your healthcare provider may request an ENA Panel if you have symptoms that could suggest a systemic autoimmune disease, such as:

Persistent joint pain or swelling

Unexplained muscle weakness

Skin rashes or photosensitivity

Dry eyes or dry mouth

Raynaud's phenomenon

Unexplained fever or fatigue

Abnormalities involving the kidneys or other organs

A positive ANA test

What happens during the test?

A healthcare professional will collect a blood sample from a vein in your arm.

The sample is sent to the laboratory for detection of specific autoantibodies.

Will I need to do anything to prepare?

Usually, no fasting or special preparation is required.

Tell your healthcare provider about medications and supplements you are taking, particularly if you are receiving treatment that affects the immune system.

Are there any risks?

The test has the usual minor risks associated with blood collection, such as:

Brief pain or discomfort

Small bruise

Minor bleeding

Rarely, light-headedness or infection

What do the results mean?

Results are generally reported for each antibody as negative, positive, or sometimes with a numerical value or antibody level, depending on the laboratory method.

A positive result means that a particular autoantibody was detected, but it does not by itself establish a diagnosis.

A negative result reduces the likelihood of some autoimmune diseases but does not completely exclude them.

Common ENA Patterns

Antibody Possible clinical significance

Anti-Sm positive Strongly supports SLE when compatible clinical findings are present

Anti-RNP positive Particularly associated with MCTD; can also occur in SLE and other diseases

Anti-Ro/SSA positive Common in Sjögren syndrome and SLE

Anti-La/SSB positive Associated particularly with Sjögren syndrome

Anti-Scl-70 positive Supports systemic sclerosis

Anti-Jo-1 positive Supports inflammatory myopathy/antisynthetase syndrome

ENA Panel and ANA Test

The ANA and ENA tests provide different information:

ANA: Broad screening test for antinuclear antibodies.

ENA Panel: Identifies specific autoantibodies against individual nuclear antigens.

A common approach is:

Clinical suspicion → ANA testing → if appropriate, specific antibody testing such as ENA

However, ENA testing should not be interpreted as a simple reflex diagnosis based solely on ANA positivity.

Important Note

A positive ENA antibody does not automatically mean that a person has an autoimmune disease. Some autoantibodies may occur in other conditions or, occasionally, in people without an established autoimmune disease.

Results should be interpreted together with ANA results, antibody levels/patterns where applicable, symptoms, physical findings, and other laboratory investigations.

The exact antibodies included in an ENA Panel and the reference ranges depend on the laboratory method and testing platform.

Prefer to talk to someone first? Contact us to book.